HUTCHMED (China) Ltd (STU:H7T1)
€ 16.1 0.5 (3.21%) Market Cap: 2.75 Bil Enterprise Value: 2.08 Bil PE Ratio: 0 PB Ratio: 4.11 GF Score: 64/100

Full Year 2020 Hutchison China MediTech Ltd Earnings Call Transcript

Mar 04, 2021 / 01:00PM GMT
Release Date Price: €23.8 (-4.03%)
Christian Hogg
Hutchison China MediTech Limited - CEO & Executive Director

Okay. Thank you. This is Christian Hogg, CEO of HUTCHMED. And today, we welcome everybody to this 2020 -- fiscal year 2020 results and business update presentation.

On the line, I also have Dr. Wei-Guo Su, our Chief Scientific Officer and Head of Research and Development. I have Johnny Cheng, our Chief Financial Officer, and I have Dr. Marek Kania, our Chief Medical Officer in the U.S. and Head of our International Operations.

What I'm planning to do today is, given this is an hour-long session, is spend about 30 minutes, 25 to 30 minutes on the presentation. I'll go through it relatively quickly as it's all fairly well laid-out in our announcement that's just been out for an hour or so. And then I'll leave the second half of the hour for Q&A. And that's an opportunity for the broader team that we have here to answer any questions that you might have.

So if we go to Page #3 of the presentation, I'll just touch very quickly on the new name, the new corporate identity, HUTCHMED. As many of you on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot